FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1592685887> ?p ?o ?g. }

• W1592685887 endingPage "1273" @default.
• W1592685887 startingPage "1272" @default.
• W1592685887 abstract "5419 Cyclooxygenase-2 ( COX-2 ) is a key inducible enzyme involved in the production of prostaglandins, and its inhibitors have been demonstrated to induce apoptosis in various cancer cells. Several anticancer agents also mediate apoptosis and may share the common intracellular pathways leading to apoptosis. Since enhance. ment of COX-2 expression has been reported in bladder cancer, we reasoned that combination treatment of bladder cancer cells with COX-2 inhibitors and anticancer agents may result in synergistic apoptosis. This study has examined whether the selective COX-2 inhibitor synergizes with anticancer agents in cytotoxicity and apoptosis against bladder cancer cells. The selective COX-2 inhibitor JTE-522 was gift from Japan Tabacco Co. Ltd. Cytotoxicity was determined by the microculture tetrazolium dye assay. Apoptosis was examined by the TUNEL assay. The mRNA expression of COX-2 was observed in T24, T24/CDDP and J82 bladder cancer cell lines and two primary cultured bladder cancer cells, but not normal bladder cells. Combination treatment of T24 cells with JTE-522 and cisplatin ( CDDP ) resulted in a synergistic cytotoxic effect. Synergy was also achieved in the CDDP-resistant T24 bladder cancer line ( T24/CDDP ), the J82 bladder cancer line and two primary cultured bladder cancer cells, but not normal bladder cells. Although treatment of T24 cells with JTE-522 and carboplatin resulted in synergistic cytotoxicity, combination treatment with JTE-522 and trans-DDP resulted in an additive cytotoxic effect. The synergistic cytotoxicity was obtained irrespective of the sequence of the treatment, and the highest cytotoxicity was obtained when T24 cells were treated with JTE-522 initially. The synergy achieved in cytotoxicity with JTE-522 and CDDP was shown to be due to apoptosis. The mechanisms responsible for the synergistic cytotoxicity and apoptosis was examined. Treatment of T24 cells with JTE-522 reduced the expression of anti-apoptotic molecule Bcl-2, but not Bcl-XL or Bax. Caspase 3 activity in T24 cells was enhanced after combination treatment with JTE-522 and CDDP. The in vivo significant growth inhibitory effect of JTE-522 and CDDP against the T24 line heterotransplanted in SCID mice was also observed. This study has demonstrated that combination treatment of bladder cancer cells with the selective COX-2 inhibitor JTE-522 and CDDP results in synergistic cytotoxicity and apoptosis in vitro and in vivo . The synergy obtained with established CDDP-resistant and primary cultured bladder cancer cells required low subtoxic concentrations of CDDP. These findings support the potential clinical application of a combination of JTE-522 and CDDP in the treatment of bladder cancer as a new form of therapy with more selective cytotoxicity and less collateral side effects." @default.
• W1592685887 created "2016-06-24" @default.
• W1592685887 creator A5002937255 @default.
• W1592685887 creator A5013174406 @default.
• W1592685887 creator A5041864474 @default.
• W1592685887 creator A5041964655 @default.
• W1592685887 creator A5052723519 @default.
• W1592685887 creator A5054076544 @default.
• W1592685887 creator A5062467354 @default.
• W1592685887 creator A5080691001 @default.
• W1592685887 creator A5082156122 @default.
• W1592685887 creator A5088773176 @default.
• W1592685887 date "2006-04-15" @default.
• W1592685887 modified "2023-09-27" @default.
• W1592685887 title "Enhanced cisplatin-mediated cytotoxicity and apoptosis against bladder cancer cells in vitro and in vivo by the selective cyclooxygenase-2 inhibitor." @default.
• W1592685887 hasPublicationYear "2006" @default.
• W1592685887 type Work @default.
• W1592685887 sameAs 1592685887 @default.
• W1592685887 citedByCount "0" @default.
• W1592685887 crossrefType "journal-article" @default.
• W1592685887 hasAuthorship W1592685887A5002937255 @default.
• W1592685887 hasAuthorship W1592685887A5013174406 @default.
• W1592685887 hasAuthorship W1592685887A5041864474 @default.
• W1592685887 hasAuthorship W1592685887A5041964655 @default.
• W1592685887 hasAuthorship W1592685887A5052723519 @default.
• W1592685887 hasAuthorship W1592685887A5054076544 @default.
• W1592685887 hasAuthorship W1592685887A5062467354 @default.
• W1592685887 hasAuthorship W1592685887A5080691001 @default.
• W1592685887 hasAuthorship W1592685887A5082156122 @default.
• W1592685887 hasAuthorship W1592685887A5088773176 @default.
• W1592685887 hasConcept C109316439 @default.
• W1592685887 hasConcept C121608353 @default.
• W1592685887 hasConcept C126322002 @default.
• W1592685887 hasConcept C154317977 @default.
• W1592685887 hasConcept C185592680 @default.
• W1592685887 hasConcept C190283241 @default.
• W1592685887 hasConcept C202751555 @default.
• W1592685887 hasConcept C2776694085 @default.
• W1592685887 hasConcept C2778239845 @default.
• W1592685887 hasConcept C2780352672 @default.
• W1592685887 hasConcept C502942594 @default.
• W1592685887 hasConcept C54355233 @default.
• W1592685887 hasConcept C55493867 @default.
• W1592685887 hasConcept C71924100 @default.
• W1592685887 hasConcept C81885089 @default.
• W1592685887 hasConcept C86803240 @default.
• W1592685887 hasConcept C96232424 @default.
• W1592685887 hasConcept C98274493 @default.
• W1592685887 hasConceptScore W1592685887C109316439 @default.
• W1592685887 hasConceptScore W1592685887C121608353 @default.
• W1592685887 hasConceptScore W1592685887C126322002 @default.
• W1592685887 hasConceptScore W1592685887C154317977 @default.
• W1592685887 hasConceptScore W1592685887C185592680 @default.
• W1592685887 hasConceptScore W1592685887C190283241 @default.
• W1592685887 hasConceptScore W1592685887C202751555 @default.
• W1592685887 hasConceptScore W1592685887C2776694085 @default.
• W1592685887 hasConceptScore W1592685887C2778239845 @default.
• W1592685887 hasConceptScore W1592685887C2780352672 @default.
• W1592685887 hasConceptScore W1592685887C502942594 @default.
• W1592685887 hasConceptScore W1592685887C54355233 @default.
• W1592685887 hasConceptScore W1592685887C55493867 @default.
• W1592685887 hasConceptScore W1592685887C71924100 @default.
• W1592685887 hasConceptScore W1592685887C81885089 @default.
• W1592685887 hasConceptScore W1592685887C86803240 @default.
• W1592685887 hasConceptScore W1592685887C96232424 @default.
• W1592685887 hasConceptScore W1592685887C98274493 @default.
• W1592685887 hasLocation W15926858871 @default.
• W1592685887 hasOpenAccess W1592685887 @default.
• W1592685887 hasPrimaryLocation W15926858871 @default.
• W1592685887 hasRelatedWork W1554848350 @default.
• W1592685887 hasRelatedWork W1695090777 @default.
• W1592685887 hasRelatedWork W2003126314 @default.
• W1592685887 hasRelatedWork W2005969350 @default.
• W1592685887 hasRelatedWork W2084547217 @default.
• W1592685887 hasRelatedWork W2101074047 @default.
• W1592685887 hasRelatedWork W2106548400 @default.
• W1592685887 hasRelatedWork W2135552329 @default.
• W1592685887 hasRelatedWork W2157514563 @default.
• W1592685887 hasRelatedWork W2174356828 @default.
• W1592685887 hasRelatedWork W2366412766 @default.
• W1592685887 hasRelatedWork W2370170061 @default.
• W1592685887 hasRelatedWork W2412157505 @default.
• W1592685887 hasRelatedWork W2467948204 @default.
• W1592685887 hasRelatedWork W2511917209 @default.
• W1592685887 hasRelatedWork W2791572058 @default.
• W1592685887 hasRelatedWork W2887611265 @default.
• W1592685887 hasRelatedWork W3022473075 @default.
• W1592685887 hasRelatedWork W3163445905 @default.
• W1592685887 hasRelatedWork W3178621207 @default.
• W1592685887 hasVolume "66" @default.
• W1592685887 isParatext "false" @default.
• W1592685887 isRetracted "false" @default.
• W1592685887 magId "1592685887" @default.
• W1592685887 workType "article" @default.